Exact Mass: 734.5485

Exact Mass Matches: 734.5485

Found 500 metabolites which its exact mass value is equals to given mass value 734.5485, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

PA(18:0/18:1(12Z)-2OH(9,10))

[(2R)-2-{[(9S,10S,12Z)-9,10-dihydroxyoctadec-12-enoyl]oxy}-3-(octadecanoyloxy)propoxy]phosphonic acid

C39H75O10P (734.5098)

PA(18:0/18:1(12Z)-2OH(9,10)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:0/18:1(12Z)-2OH(9,10)), in particular, consists of one chain of one octadecanoyl at the C-1 position and one chain of 9,10-hydroxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(18:1(12Z)-2OH(9,10)/18:0)

[(2R)-3-{[(9R,10R,12Z)-9,10-dihydroxyoctadec-12-enoyl]oxy}-2-(octadecanoyloxy)propoxy]phosphonic acid

C39H75O10P (734.5098)

PA(18:1(12Z)-2OH(9,10)/18:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:1(12Z)-2OH(9,10)/18:0), in particular, consists of one chain of one 9,10-hydroxy-octadecenoyl at the C-1 position and one chain of octadecanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(i-18:0/18:1(12Z)-2OH(9,10))

[(2R)-2-{[(9S,10S,12Z)-9,10-dihydroxyoctadec-12-enoyl]oxy}-3-[(16-methylheptadecanoyl)oxy]propoxy]phosphonic acid

C39H75O10P (734.5098)

PA(i-18:0/18:1(12Z)-2OH(9,10)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(i-18:0/18:1(12Z)-2OH(9,10)), in particular, consists of one chain of one 16-methylheptadecanoyl at the C-1 position and one chain of 9,10-hydroxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(18:1(12Z)-2OH(9,10)/i-18:0)

[(2R)-3-{[(9R,10R,12Z)-9,10-dihydroxyoctadec-12-enoyl]oxy}-2-[(16-methylheptadecanoyl)oxy]propoxy]phosphonic acid

C39H75O10P (734.5098)

PA(18:1(12Z)-2OH(9,10)/i-18:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:1(12Z)-2OH(9,10)/i-18:0), in particular, consists of one chain of one 9,10-hydroxy-octadecenoyl at the C-1 position and one chain of 16-methylheptadecanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

DG(21:0/PGE2/0:0)

(2S)-3-Hydroxy-2-{[(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoyl]oxy}propyl henicosanoic acid

C44H78O8 (734.5696)

DG(21:0/PGE2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(21:0/PGE2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(PGE2/21:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoyl]oxy}propan-2-yl henicosanoic acid

C44H78O8 (734.5696)

DG(PGE2/21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGE2/21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(21:0/0:0/PGE2)

(2R)-2-Hydroxy-3-{[(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoyl]oxy}propyl henicosanoic acid

C44H78O8 (734.5696)

DG(21:0/0:0/PGE2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(PGE2/0:0/21:0)

(2S)-2-Hydroxy-3-{[(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoyl]oxy}propyl henicosanoic acid

C44H78O8 (734.5696)

DG(PGE2/0:0/21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(21:0/PGD2/0:0)

(2S)-3-Hydroxy-2-{[(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoyl]oxy}propyl henicosanoic acid

C44H78O8 (734.5696)

DG(21:0/PGD2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(21:0/PGD2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(PGD2/21:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoyl]oxy}propan-2-yl henicosanoic acid

C44H78O8 (734.5696)

DG(PGD2/21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGD2/21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(21:0/0:0/PGD2)

(2R)-2-Hydroxy-3-{[(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoyl]oxy}propyl henicosanoic acid

C44H78O8 (734.5696)

DG(21:0/0:0/PGD2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(PGD2/0:0/21:0)

(2S)-2-Hydroxy-3-{[(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoyl]oxy}propyl henicosanoic acid

C44H78O8 (734.5696)

DG(PGD2/0:0/21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(21:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0)

(2S)-3-hydroxy-2-{[(5S,6S,7E,9E,11Z,13E,15S)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoyl]oxy}propyl henicosanoate

C44H78O8 (734.5696)

DG(21:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(21:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/21:0/0:0)

(2S)-1-Hydroxy-3-{[(5R,6R,7E,9E,11Z,15R)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoyl]oxy}propan-2-yl henicosanoic acid

C44H78O8 (734.5696)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(21:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

(2R)-2-hydroxy-3-{[(5R,6R,7E,9E,11Z,13E,15R)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoyl]oxy}propyl henicosanoate

C44H78O8 (734.5696)

DG(21:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/21:0)

(2S)-2-Hydroxy-3-{[(5R,6R,7E,9E,11Z,15R)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoyl]oxy}propyl henicosanoic acid

C44H78O8 (734.5696)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-21:0/PGE2/0:0)

(2S)-3-Hydroxy-2-{[(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoyl]oxy}propyl 18-methylicosanoic acid

C44H78O8 (734.5696)

DG(a-21:0/PGE2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-21:0/PGE2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(PGE2/a-21:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoyl]oxy}propan-2-yl 18-methylicosanoic acid

C44H78O8 (734.5696)

DG(PGE2/a-21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGE2/a-21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-21:0/0:0/PGE2)

(2R)-2-Hydroxy-3-{[(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoyl]oxy}propyl 18-methylicosanoic acid

C44H78O8 (734.5696)

DG(a-21:0/0:0/PGE2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(PGE2/0:0/a-21:0)

(2S)-2-Hydroxy-3-{[(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoyl]oxy}propyl 18-methylicosanoic acid

C44H78O8 (734.5696)

DG(PGE2/0:0/a-21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-21:0/PGD2/0:0)

(2S)-3-Hydroxy-2-{[(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoyl]oxy}propyl 18-methylicosanoic acid

C44H78O8 (734.5696)

DG(a-21:0/PGD2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-21:0/PGD2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(PGD2/a-21:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoyl]oxy}propan-2-yl 18-methylicosanoic acid

C44H78O8 (734.5696)

DG(PGD2/a-21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGD2/a-21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-21:0/0:0/PGD2)

(2R)-2-Hydroxy-3-{[(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoyl]oxy}propyl 18-methylicosanoic acid

C44H78O8 (734.5696)

DG(a-21:0/0:0/PGD2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(PGD2/0:0/a-21:0)

(2S)-2-Hydroxy-3-{[(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoyl]oxy}propyl 18-methylicosanoic acid

C44H78O8 (734.5696)

DG(PGD2/0:0/a-21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-21:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0)

(2S)-1-hydroxy-3-[(18-methylicosanoyl)oxy]propan-2-yl (5S,6S,7E,9E,11Z,13E,15S)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoate

C44H78O8 (734.5696)

DG(a-21:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-21:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/a-21:0/0:0)

(2S)-3-Hydroxy-2-[(18-methylicosanoyl)oxy]propyl (5R,6R,7E,9E,11Z,15R)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoic acid

C44H78O8 (734.5696)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/a-21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/a-21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-21:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

(2R)-2-hydroxy-3-[(18-methylicosanoyl)oxy]propyl (5R,6R,7E,9E,11Z,13E,15R)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoate

C44H78O8 (734.5696)

DG(a-21:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/a-21:0)

(2S)-2-hydroxy-3-[(18-methylicosanoyl)oxy]propyl (5R,6R,7E,9E,11Z,13E,15R)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoate

C44H78O8 (734.5696)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/a-21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-21:0/PGE2/0:0)

(2S)-3-Hydroxy-2-{[(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoyl]oxy}propyl 19-methylicosanoic acid

C44H78O8 (734.5696)

DG(i-21:0/PGE2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-21:0/PGE2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(PGE2/i-21:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoyl]oxy}propan-2-yl 19-methylicosanoic acid

C44H78O8 (734.5696)

DG(PGE2/i-21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGE2/i-21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-21:0/0:0/PGE2)

(2R)-2-Hydroxy-3-{[(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoyl]oxy}propyl 19-methylicosanoic acid

C44H78O8 (734.5696)

DG(i-21:0/0:0/PGE2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(PGE2/0:0/i-21:0)

(2S)-2-Hydroxy-3-{[(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoyl]oxy}propyl 19-methylicosanoic acid

C44H78O8 (734.5696)

DG(PGE2/0:0/i-21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-21:0/PGD2/0:0)

(2S)-3-Hydroxy-2-{[(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoyl]oxy}propyl 19-methylicosanoic acid

C44H78O8 (734.5696)

DG(i-21:0/PGD2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-21:0/PGD2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(PGD2/i-21:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoyl]oxy}propan-2-yl 19-methylicosanoic acid

C44H78O8 (734.5696)

DG(PGD2/i-21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGD2/i-21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-21:0/0:0/PGD2)

(2R)-2-Hydroxy-3-{[(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoyl]oxy}propyl 19-methylicosanoic acid

C44H78O8 (734.5696)

DG(i-21:0/0:0/PGD2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(PGD2/0:0/i-21:0)

(2S)-2-Hydroxy-3-{[(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoyl]oxy}propyl 19-methylicosanoic acid

C44H78O8 (734.5696)

DG(PGD2/0:0/i-21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-21:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0)

(2S)-1-hydroxy-3-[(19-methylicosanoyl)oxy]propan-2-yl (5S,6S,7E,9E,11Z,13E,15S)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoate

C44H78O8 (734.5696)

DG(i-21:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-21:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/i-21:0/0:0)

(2S)-3-hydroxy-2-[(19-methylicosanoyl)oxy]propyl (5R,6R,7E,9E,11Z,13E,15R)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoate

C44H78O8 (734.5696)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/i-21:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/i-21:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-21:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

(2R)-2-hydroxy-3-[(19-methylicosanoyl)oxy]propyl (5R,6R,7E,9E,11Z,13E,15R)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoate

C44H78O8 (734.5696)

DG(i-21:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/i-21:0)

(2S)-2-hydroxy-3-[(19-methylicosanoyl)oxy]propyl (5R,6R,7E,9E,11Z,13E,15R)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoate

C44H78O8 (734.5696)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/i-21:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

Thioetheramide-PC

1,2-dideoxy-1-(S-hexadecyl)thio-2-(N-hexadecanoyl)amino-sn-glyceryl-3-phosphorylcholine

C40H83N2O5PS (734.576)

PG(13:0/20:1(11Z))

1-tridecanoyl-2-(11Z-eicosenoyl)-glycero-3-phospho-(1-sn-glycerol)

C39H75O10P (734.5098)

PG(14:0/19:1(9Z))

1-tetradecanoyl-2-(9Z-nonadecenoyl)-glycero-3-phospho-(1-sn-glycerol)

C39H75O10P (734.5098)

PG(14:1(9Z)/19:0)

1-(9Z-tetradecenoyl)-2-nonadecanoyl-glycero-3-phospho-(1-sn-glycerol)

C39H75O10P (734.5098)

PG(15:0/18:1(9Z))

1-pentadecanoyl-2-(9Z-octadecenoyl)-glycero-3-phospho-(1-sn-glycerol)

C39H75O10P (734.5098)

PG(15:1(9Z)/18:0)

1-(9Z-pentadecenoyl)-2-octadecanoyl-glycero-3-phospho-(1-sn-glycerol)

C39H75O10P (734.5098)

PG(16:1(9Z)/17:0)

1-(9Z-hexadecenoyl)-2-heptadecanoyl-glycero-3-phospho-(1-sn-glycerol)

C39H75O10P (734.5098)

PG(17:0/16:1(9Z))

1-heptadecanoyl-2-(9Z-hexadecenoyl)-glycero-3-phospho-(1-sn-glycerol)

C39H75O10P (734.5098)

PG(17:1(9Z)/16:0)

1-(9Z-heptadecenoyl)-2-hexadecanoyl-glycero-3-phospho-(1-sn-glycerol)

C39H75O10P (734.5098)

PG(18:0/15:1(9Z))

1-octadecanoyl-2-(9Z-pentadecenoyl)-glycero-3-phospho-(1-sn-glycerol)

C39H75O10P (734.5098)

PG(18:1(9Z)/15:0)

1-(9Z-octadecenoyl)-2-pentadecanoyl-glycero-3-phospho-(1-sn-glycerol)

C39H75O10P (734.5098)

PG(19:0/14:1(9Z))

1-nonadecanoyl-2-(9Z-tetradecenoyl)-glycero-3-phospho-(1-sn-glycerol)

C39H75O10P (734.5098)

PG(19:1(9Z)/14:0)

1-(9Z-nonadecenoyl)-2-tetradecanoyl-glycero-3-phospho-(1-sn-glycerol)

C39H75O10P (734.5098)

PG(20:1(11Z)/13:0)

1-(11Z-eicosenoyl)-2-tridecanoyl-glycero-3-phospho-(1-sn-glycerol)

C39H75O10P (734.5098)

PG(16:0/17:1(9Z))

1-hexadecanoyl-2-(9Z-heptadecenoyl)-glycero-3-phospho-(1-sn-glycerol)

C39H75O10P (734.5098)

PG(O-20:0/14:1(9Z))

1-eicosyl-2-(9Z-tetradecenoyl)-glycero-3-phospho-(1-sn-glycerol)

C40H79O9P (734.5461)

PG(O-18:0/16:1(9Z))

1-octadecyl-2-(9Z-hexadecenoyl)-glycero-3-phospho-(1-sn-glycerol)

C40H79O9P (734.5461)

PG(O-16:0/18:1(9Z))

1-hexadecyl-2-(9Z-octadecenoyl)-glycero-3-phospho-(1-sn-glycerol)

C40H79O9P (734.5461)

PG(P-16:0/18:0)

1-(1Z-hexadecenyl)-2-octadecanoyl-glycero-3-phospho-(1-sn-glycerol)

C40H79O9P (734.5461)

PG(P-18:0/16:0)

1-(1Z-octadecenyl)-2-hexadecanoyl-glycero-3-phospho-(1-sn-glycerol)

C40H79O9P (734.5461)

PG(P-20:0/14:0)

1-(1Z-eicosenyl)-2-tetradecanoyl-glycero-3-phospho-(1-sn-glycerol)

C40H79O9P (734.5461)

PA(O-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

1-octadecyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-glycero-3-phosphate

C43H75O7P (734.525)

PA(P-20:0/20:5(5Z,8Z,11Z,14Z,17Z))

1-(1Z-eicosenyl)-2-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)-glycero-3-phosphate

C43H75O7P (734.525)

PG 33:1

1-hexadecanoyl-2-(9R, 11S-methylene-hexadecanoyl)-sn-glycero-3-phospho-(1-sn-glycerol)

C39H75O10P (734.5098)

PG O-34:1

1-(1Z-octadecenyl)-2-hexadecanoyl-glycero-3-phospho-(1-sn-glycerol)

C40H79O9P (734.5461)

PA O-40:6

1-(1Z-eicosenyl)-2-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)-glycero-3-phosphate

C43H75O7P (734.525)

Dihydroxylycopene glucoside

1-(beta-D-glucopyranosyloxy)-1,2,1,2-tetrahydro-psi,psi-carotene

C46H70O7 (734.5121)

II-dihydro-omega-(2,6,6-trimethylcyclohex-2-enylmethyl)2,3-epoxymenaquinone-6

(2E,10E,14E,18E,22E)-2-[3,7,11,15,19,23-hexamethyl-25-(2,6,6-trimethyl-cyclohex-2-enyl)pentacosa-2,10,14,18,22-pentaenyl]-3-methyl-2,3-dihydro-2,3-epoxy-1,4-naphthoquinone

C51H74O3 (734.5638)